Cladribine plus rituximab is an effective therapy for newly diagnosed mantle cell lymphoma.
Saved in:
| Title: | Cladribine plus rituximab is an effective therapy for newly diagnosed mantle cell lymphoma. |
|---|---|
| Authors: | Spurgeon SE; Knight Cancer Institute at Oregon Health and Science University, Portland, OR 97239-3098, USA. spurgeos@ohsu.edu, Pindyck T, Okada C, Chen Y, Chen Z, Mater E, Abbi K, Epner EM |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2011 Aug; Vol. 52 (8), pp. 1488-94. Date of Electronic Publication: 2011 May 31. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1029-2403 |
|---|---|
| DOI: | 10.3109/10428194.2011.575489 |
